Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pyridine | HCID 1049 | — |
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | Phenyl chloroformate | HCID 15891 | — |
| Reactant | HCID 178432506 | HCID 178432506 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 135508486 | HCID 135508486 | — |
Reaction Steps
138 mg of 2-Fluoro-N-hydroxy-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-benzamidine were dissolved in 2 ml dichloromethane. 35 μl pyridine and 53 μl phenylchloroformate were added and the mixture stirred at room temperature for thirty minutes. The mixture was diluted by the addition of 20 ml ethyl acetate, washed with brine and dried over MgSO4. The solvent was evaporated in vacuo. The resulting residue was dissolved in 2 ml acetonitrile and 105 μl 1,8-Diazabicyclo[5.4.0]undec-7-ene was added. The mixture was stirred at room temperature for 10 minutes. The mixture was evaporated in vacuo and the resulting crude material was purified by reversed phase HPLC to obtain 70 mg 3-{2-Fluoro-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazole-5-one as an amorphous lyophilisate.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07709509B2 |
|---|
| Source dataset | uspto-grants-2010_05 |
|---|
| ORD ID | ord-0299eeb0863e4d7eba0b4621a684514f |
|---|
| Source note | uspto-grants-2010_05 |
|---|